IDXX
Price
$494.38
Change
+$0.58 (+0.12%)
Updated
Apr 24, 6:59 PM EST
7 days until earnings call
PEN
Price
$206.07
Change
+$0.37 (+0.18%)
Updated
Apr 24, 6:59 PM EST
13 days until earnings call
Ad is loading...

Compare predictions IDXX vs PEN

Header iconIDXX vs PEN Comparison
Open Charts IDXX vs PENBanner chart's image
IDEXX Laboratories
Price$494.38
Change+$0.58 (+0.12%)
Volume$187.77K
CapitalizationN/A
Penumbra
Price$206.07
Change+$0.37 (+0.18%)
Volume$95.87K
CapitalizationN/A
View a ticker or compare two or three
IDXX vs PEN Comparison Chart

Loading...

IDXXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
IDXX vs. PEN commentary
Apr 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXX is a Hold and PEN is a Buy.

COMPARISON
Comparison
Apr 24, 2024
Stock price -- (IDXX: $493.80 vs. PEN: $205.70)
Brand notoriety: IDXX and PEN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IDXX: 139% vs. PEN: 101%
Market capitalization -- IDXX: $44.84B vs. PEN: $8.64B
IDXX [@Medical Specialties] is valued at $44.84B. PEN’s [@Medical Specialties] market capitalization is $8.64B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDXX’s FA Score shows that 1 FA rating(s) are green whilePEN’s FA Score has 0 green FA rating(s).

  • IDXX’s FA Score: 1 green, 4 red.
  • PEN’s FA Score: 0 green, 5 red.
According to our system of comparison, IDXX is a better buy in the long-term than PEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDXX’s TA Score shows that 4 TA indicator(s) are bullish while PEN’s TA Score has 4 bullish TA indicator(s).

  • IDXX’s TA Score: 4 bullish, 4 bearish.
  • PEN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both IDXX and PEN are a good buy in the short-term.

Price Growth

IDXX (@Medical Specialties) experienced а +0.86% price change this week, while PEN (@Medical Specialties) price change was -2.07% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.37%. For the same industry, the average monthly price growth was -2.96%, and the average quarterly price growth was +16.03%.

Reported Earning Dates

IDXX is expected to report earnings on Jul 30, 2024.

PEN is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Medical Specialties (+1.37% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for IDXX with price predictions.
OPEN
A.I.dvisor published
a Summary for PEN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IDXX($44.8B) has a higher market cap than PEN($8.64B). PEN has higher P/E ratio than IDXX: PEN (93.70) vs IDXX (52.87). IDXX YTD gains are higher at: -11.035 vs. PEN (-18.224). IDXX has higher annual earnings (EBITDA): 1.22B vs. PEN (109M). IDXX has more cash in the bank: 454M vs. PEN (289M). PEN has less debt than IDXX: PEN (234M) vs IDXX (1.07B). IDXX has higher revenues than PEN: IDXX (3.66B) vs PEN (1.06B).
IDXXPENIDXX / PEN
Capitalization44.8B8.64B519%
EBITDA1.22B109M1,117%
Gain YTD-11.035-18.22461%
P/E Ratio52.8793.7056%
Revenue3.66B1.06B346%
Total Cash454M289M157%
Total Debt1.07B234M456%
FUNDAMENTALS RATINGS
IDXX vs PEN: Fundamental Ratings
IDXX
PEN
OUTLOOK RATING
1..100
5572
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
4163
SMR RATING
1..100
1577
PRICE GROWTH RATING
1..100
6064
P/E GROWTH RATING
1..100
7899
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IDXX's Valuation (87) in the Medical Specialties industry is in the same range as PEN (93). This means that IDXX’s stock grew similarly to PEN’s over the last 12 months.

IDXX's Profit vs Risk Rating (41) in the Medical Specialties industry is in the same range as PEN (63). This means that IDXX’s stock grew similarly to PEN’s over the last 12 months.

IDXX's SMR Rating (15) in the Medical Specialties industry is somewhat better than the same rating for PEN (77). This means that IDXX’s stock grew somewhat faster than PEN’s over the last 12 months.

IDXX's Price Growth Rating (60) in the Medical Specialties industry is in the same range as PEN (64). This means that IDXX’s stock grew similarly to PEN’s over the last 12 months.

IDXX's P/E Growth Rating (78) in the Medical Specialties industry is in the same range as PEN (99). This means that IDXX’s stock grew similarly to PEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDXXPEN
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
68%
Bearish Trend 7 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
IDXXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WEAV11.120.23
+2.11%
Weave Communications
SHIP9.460.14
+1.50%
Seanergy Maritime Holdings Corp
CSTM21.330.20
+0.95%
Constellium SE
WBA18.05-0.17
-0.93%
Walgreens Boots Alliance
IMRN2.46-0.14
-5.44%
Immuron Limited